Dr. Nikhil S Ghadyalpatil

Education Qualifications

• 2006-2009: DM (Medical Oncology), Tata Memorial Hospital, Mumbai
• 2006: Diplomate of National Board (DNB), Seth G. S. Medical College and KEM Hospital, Mumbai
• 2003-2006: MD (Internal Medicine), Seth G. S. Medical College and KEM Hospital, Mumbai
• 2001-2002: Clinical Rotating Internship, Government Medical College, Nagpur
• 1996-2001: MBBS, Government Medical College, Nagpur

Experience

• April 2010-Present: Senior Consultant Medical Oncologist & Hemato-Oncologist, Yashoda Hospitals, Somajiguda
• 2009-2010: Ad-Hoc Consultant Medical Oncology, Tata Memorial Center
• Experience in Multiple Clinical Trials

Services offered

• Cancer Treatment/Therapies in Medical Oncology
• Chemotherapy
• Targeted Therapy/Precision Oncology
• Head and Neck Cancer Treatment (Oral Cancer/Buccal Mucosa Cancer/Throat Cancer/Larynx Cancer/Hypopharynx Cancer)
• Breast Cancer Treatment
• Solid Tumors (Breast Cancer, Lung Cancer, Gastrointestinal Cancer (Pancreatic Cancer, Gallbladder Cancer, Colon/Intestinal Cancer), Sarcoma, Bone Cancer, Gynecological Cancers (Cervical Cancer, Uterine Cancer, Ovarian Cancer), Genitourinary Cancer (Testicular Cancer, Bladder Cancer, Prostate Cancer), Medical Oncology, Management of Brain Tumors
• Pediatric Oncology/Childhood Cancers
• Supportive and Palliative Care
• Cancer Nutrition
• Cancer Survivorship

Special Interest and Expertise

• Immunotherapy
• Hematological Malignancies/Blood Cancers/Lymphoma/Leukemia/Multiple Myeloma
• Solid Tumors
• Pediatric Oncology
• Cancer Nutrition
• Precision Oncology

Professional Membership

• American Society of Clinical Oncology (ASCO)
• European Society of Clinical Oncology (ESMO)
• Indian Society of Medical and Pediatric Oncology (ISMPO)
• Indian Cooperative Oncology Network (ICON)

Research & Publications

• Purvish M. Parikh, Sachin Hingmire, Nikhil Ghadyalpatil. Next Wave of COVID-19: Lessons for India from Indonesia, Israel, and Iceland. South Asian J Cancer 2021; 00:1–3
• Anant Ramaswamy, Kripa Bajaj, Vineet Talwar, Kumar Prabhash, Ullas Batra, Boman Dhabhar, Mansi Sharma, Nikhil Ghadyalpatil, Satish CT, Gautam Goyal, Javvid Muzamil, Amit Bhatt, Parveen Jain, Anantbhushan Ranade, Mangesh Kamath, Jayant Pundlik Gawande, Ravi Thippeswamy, Jimmy Mirani, Neelesh Reddy, Sandip Ganguly, Sourav Kumar Mishra, Irappa Madabhavi, Shashidhara HP, Soumya Surath Panda, Shekar Patil, Prabhat Bhargava, Vikas Ostwal. Ramucirumab in Indian Patients with Advanced Gastric Cancer—Does Borderline Performance Status and Heavy Burden of Disease in Real World Practice Impact Clinical Benefit? South Asian J Cancer 2021; 00:1–7
• Ghanshyam Biswas, Avinash Pandey, Nikhil Ghadyalpatil, Nilesh Lokeshwar, Boben Thomas, Anita Ramesh,Yogesh Arora, Chandragouda Dodagoudar, Vibha Naik, Ashish Joshi, Indranil Ghosh, Rakesh Roy, Medhi Kunjahari, Tejinder Singh, Palanki Dattatreya Satya, Sachin Hingmire, Purvish M Parikh. Role of Cresp® in the management of chemotherapy‑induced anemia in cancer patients: A real‑world clinical practice audit. South Asian J Cancer 2020; 9:59-61
• Purvish M. Parikh, P. Narayanan, A. Vora, A. Gulia, S. K. Mullapally, B. Rangrajan, S. Gupta, P. Mehta, S. Hingmire, P. Kulkarni, B. Parekh, N. Ghadyalpatil, G. Babu, R. Singh. Conflict of interest disclosure and interpretation - rest assured the medical professional in the audience is perceptive, alert and smart. Indian J Med Sci 2019;x(x):1-5
• Bhavesh Parekh, N. Ghadlyalpatil, E. V. Chandarana, S. S. Hingmire, Gupta Sumant, V. Agarwala, A. Tiwari, G. S. Bhattacharyya, P. M. Parikh. Immunotherapy in esophageal cancer – An update. International Journal of Molecular & Immuno Oncology, Volume 4, Issue 2, September-December 2019
• Ghadyalpatil NS, Pandey A, Krishnamani I, Srinivas C, Rafiq SJ, Hingmire SS, et al. First-line management of metastatic non-small cell lung cancer: An Indian perspective. South Asian J Cancer 2019; 8:73-9
• Parikh P M, Bhattacharyya G S, Hingmire S S, Mehta P, Rangrajan B, Ganesh Natrajan, Ghadyalpatil N, Narayanan P, Singh Randeep, Parekh Bhavesh, Singhal M. “Our patient at risk from unauthorized, unapproved, illegally imported fake "generic medicines”. Indian Journal of Medical Science 2018 September-December;70(3):43-47
• Anant Ramaswamy, Vikas Ostwal, Nikhil Pande, Atul Sharma, Shekar Patil, Ravi Thippeswamy, Nikhil Ghadyalpatil, Rakesh Roy, Harish Peshwe, Bhavesh Poladia, Deepan Rajamanickam, Bharat Rangarajan, P. R. Neelesh Reddy, Vimal Pandita, Ashis Mukherjee, Aniket Thoke, Abhijit Sarkar, C. T. Satish, H. Shashidara, S. D. Banavali. Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer ‑An Indian exploratory analysis study, South Asian J Cancer 2019;8:22-6
• Parikh PM, Bhattacharyya GS, Hingmire SS, Kulkarni P, Eswaran P, Jhaveri KK, Gandhi PA, Mehta P, Babu G, Rangrajan B, Ghadyalpatil N, Bahl A, Narayanan P. Consent from new patient at first registration, Indian Journal of Medical Science 2018 April: June;70(2):29-33
• Reena Nair, Abhishek Kakroo, Ajay Bapna, Ajay Gogia, Amish Vora, Anand Pathak, Anu Korula, Anupam Chakrapani, Dinesh Doval, Gaurav Prakash, Ghanashyam Biswas, Hari Menon, Maitreyee Bhattacharya, Mammen Chandy, Mayur Parihar, M. Vamshi Krishna, Neeraj Arora, Nikhil Gadhyalpatil, Pankaj Malhotra, Prasad Narayanan, Rekha Nair, Rimpa Basu, Sandip Shah, Saurabh Bhave, Shailesh Bondarde, Shilpa Bhartiya, Soniya Nityanand, Sumeet Gujral, T. V. S. Tilak, Vivek Radhakrishnan. Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group, Indian J Hematol Blood Transfus (July-Sept 2018) 34(3):398–421
• Babu G, Bahl A, Bhattacharya GS, Bhowmik KT, Dattatraya PS, Ghadyalpatil N, et al. Oncology gold standard® practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neck. South Asian J Cancer 2017; 6:154-60
• Purvish M. Parikh, S. S. Hingmire, P. Bhavesh, K. Babu Govind, P. Mehta, A. Verma, S. Bondarde, R. Singh, N. Ghadyalpatil, B. Rangrajan, G. S. Bhattacharyya, H. Malhotra, D. C. Doval, A. A. Ranade, P. M. Shah. Oncology Gold Standard™ consensus statement on counseling patients for molecular testing and personalized cancer care. Int J Mol ImmunoOncol 2017; 2:1-11
• Under the aegis of Lung Cancer Consortium Asia (LCCA), Indian Cooperative Oncology Network (ICON), Indian Society of Medical & Pediatric Oncology (ISMPO), Molecular Oncology Society (MOS) and Association of Physicians of India API). Indian consensus statement for treatment of advanced non-small cell lung cancer: First line, maintenance, and second line. Indian Journal of Cancer | Volume 54 | Issue 1 | January-March 2017
• Vedang Murthy, Adnan Calcuttawala, Kirti Chadha, Anil d'Cruz, Arvind Krishnamurthy, Indranil Mallick, Sudhir Nair, Tanuja Teni, Sagar Pawar, Kaustav Talapatra, Asawari Patil, Amit Bhatt, Sanjoy Chatterjee, Monali Swain, Prasad Narayanan, Nikhil Ghadyalpatil, Manish Singhal, Moni Kuriakose, Kumar Prabhash, Jaiprakash Agarwal, Purvish Parikh. Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations. South Asian Journal of Cancer, Year 2017, Volume 6, Issue 3 [p. 93-98]
• U Batra, PM Parikh, K Prabhash, HB Tongaonkar, and Expert Group Members, P Chibber, D Dabkara, C Deshmukh, N Ghadyalpatil, S Hingmire, A Joshi, SK Raghunath, S Rajappa, R Rajendranath, SK Rawal, Manisha Singh, R Singh, SP Somashekhar, and R Sood. Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma. South Asian J Cancer. 2016 Oct-Dec; 5(4): 167–175
• Patil V, Noronha V, Joshi A, Parikh P, Bhattacharjee A, Chakraborty S, Jandyal S, Muddu V, Ramaswamy A, Babu KG, Lokeshwar N, Hingmire S, Ghadyalpatil N, Banavali S, Prabhash K. Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical Guideline. J Glob Oncol. 2016 Nov 9;3(4):346-359
• Ghadyalpatil NS, Chopra S, Patil P, et al. Gastrointestinal Cancers in India: Treatment perspective. South Asian J Cancer. 2016; 5:126–36.
• P. M. Parikh, A. A. Ranade, Babu Govind, N. Ghadyalpatil, R. Singh, R. Bharath, G. S. Bhattacharyya, S. Koyande, M. Singhal, A. Vora, A. Verma, and S. Hing. Lung cancer in India: Current status and promising strategies. South Asian J Cancer. 2016 Jul-Sep; 5(3): 93–95
• Kumar P, Bajpai J1, Shetty N, Medekar A, Kurkure PA, Ghadyalpatil N, Gupta S, Noronha V, Kanujia A, Parikh P, Banavali SD. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice. Indian J Cancer. 2014 Oct-Dec;51(4):491-5
• Ghadyalpatil NS, R Chandrasekar, D Snehalatha, BM Reddy. A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy. IJMPO Oct-Dec 2011. Volume 32, Issue 4.207-210.
• Kumar P, Medhekar A, Ghadyalpatil NS, Noronha V, Biswas S, Kurkure P, Nair R, Kelkar R, Banavali SD. The effect of age on the bacteria isolated and the antibiotic-sensitivity pattern in infections among cancer patients. Indian J Cancer. 2010 Oct Dec;47(4):391-6.
• Prabhash K, Medhekar A, Ghadyalpatil N, Noronha V, Biswas S, Kurkure P, Nair R, Kelkar R. Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern. Indian J Cancer. 2010 Apr-Jun;47(2):184-8
• Mardikar HM, Deshpande NV, Ghadyalpatil NS, Mardikar M. Patent protection: a need for value-based patents. Lancet 2003 Feb 15;361(9357):613
• Purvish M. Parikh, S. S. Hingmire, P. Bhavesh, K. Babu Govind, P. Mehta, A. Verma, S. Bondarde, R. Singh, N. Ghadyalpatil, B. Rangrajan, G. S. Bhattacharyya, H. Malhotra, D. C. Doval, A. A. Ranade, P. M. Shah. Oncology Gold Standard™ consensus statement on counseling patients for molecular testing and personalized cancer care. Int J Mol ImmunoOncol 2017;2:1-11 ● Under the aegis of Lung Cancer Consortium Asia (LCCA), Indian Cooperative Oncology Network (ICON), Indian Society of Medical & Pediatric Oncology (ISMPO), Molecular Oncology Society (MOS) and Association of Physicians of India API). Indian consensus statement for treatment of advanced non small cell lung cancer: First line, maintenance, and second line. Indian Journal of Cancer | Volume 54 | Issue 1 | January-March 2017 (Co Author)
• Kumar P, Bajpai J, Shetty N, Medekar A, Kurkure PA, Ghadyalpatil N, Gupta S, Noronha V, Kanujia A, Parikh P, Banavali SD. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice. Indian J Cancer. 2014 Oct-Dec;51(4):491-5
• Ghadyalpatil NS, R Chandrasekar, D Snehalatha, BM Reddy. A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy. IJMPO Oct-Dec 2011. Volume 32, Issue 4.207-210.
• Poster Presentation
  • HM Mardikar, NV Deshpande,Aziz Khan, Nikhil Ghadyalpatil. Is Coronary Angioplasty Inflammatory? Indian Heart Journal/abstract, Sept-Oct 03.
  • Aziz Khan, NV Deshpande, HM Mardikar, Nikhil Ghadyalpatil, Manjusha Mardikar. A Comparative Study of Anti-Factor Xa Activity of Parnaparin Versus Enoxaparin in Patients Undergoing Elective Coronary Angiography. Indian Heart Journal/abstract Sept Oct 03.
  • H. Menon, S. S. Hingmire, R. Bharath, K. Jain, N. Ghadyalpatil, N. Prasad, G. Biswas, C. Deshmukh, P. Sastry and P. M. Parikh. Outcome of patients of CML in AP and BC with Imatinib: A retrospective analysis of patients from India. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007:17531.
  • A. V. Bakshi, R. Bharath, S. Gupta, R. Nair, T. Shet, N. S. Ghadyalpatil, R. Kaushal, K. Gaikwad, S. Kannan, P. M. Parikh. Evaluation of efficacy and safety of neoadjuvant chemotherapy with weekly paclitaxel in patients with locally advanced and large operable breast cancer. J Clin Oncol 26: 2008 (May 20 suppl; abstr 11593).
  • R. Bharath, H. Menon, N.S.Ghadyalpatil, K. Prabhash, S. S. Hingmire, N. Karanth, K. Jain, K. Gaikwad, J. P. Agarwal and P. M. Parikh. Treatment outcomes in patients with extensive stage small cell lung cancer - Experience from a tertiary Indian cancer centre. Journal of Clinical Oncology, 2008. ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 26, No 15S (May 20 Supplement), 2008.
  • Kumar Prabhash, Ashish Bakshi, Navin Khattry, Bharath R, Tanveer Maksud, Sachin Hingmire, Kunal Jain, Nikhil Ghadyalpatil, Sushil Mandhaniya, Narayan Karanth, Purvish Parikh. Outcome of patients of AML after Haematopoietic Stem Cell Transplantation-A single institution in India. ONCOCON 2009, Chennai India.
  • K. Prabhash, T. Vora, N. S. Ghadyalpatil, B. Rangarajan, S. S. Hingmire, H. Menon, P. Jain, P. A. Kurkure,P. M. Parikh. Patterns of imatinib resistance mutation analysis in chronic myeloid leukemia (CML) patients on imatinib at the time of loss of response to the drug in Asian Indian subjects. J Clin Oncol 27:15s, 2009 (suppl; abstr 7079).
• Posters
  • Ghadyalpatil NS, Menon H, Bharath R, Aggarwal.J.P, Kumar.P, Prasad.N, Goyal L Jain.P, Pramesh.CS, Parikh PM. Induction Chemotherapy Followed By Sequential Radiotherapy Or Chemoradiotherapy In Limited Stage Small Cell Lung Cancer - Experience From A Single Tertiary Indian Cancer Centre. ESMO Sweden, 2008.
  • Menon.H, Raut.N, Ghadyalpatil. N, Prabhash.K, Parikh.P.M. Gefitinib as first line therapy in Indian population with advanced adenocarcinoma lung; A prospective study. WCLC 2009 San Francisco.
  • Kumar Prabhash, Nikhil Ghadyalpatil, P.M. Parikh,C.S.Pramesh, R. Mistry, Priyanka Kudale, Neeta Hule, Shrushti. Demographic profile of consecutive lung cancer patients-Experience from of a single centre. Asia Pacific Lung Cancer Conference, Hyderabad, 2008.
  • Ameya Medhekar, Kumar Prabhash, Rohini Kelkar, Sanjay Biswas, Nikhil Ghadyalpatil, Randeep Singh, Purna Kurkure. The effect of age on the bacteria isolated and the antibiotic sensitivity pattern in infections among cancer patients. 11th International Symposium on Febrile Neutropenia, Spain, 2009.
  • Ameya Medhekar, Kumar Prabhash, Rohini Kelkar, Sanjay Biswas, Nikhil Ghadyalpatil, Amol Akare, Bhausaheb, Purna Kurkure. Comparison of in vitro activities of ceftizidime, piperacillin-tazobactum and cefoperazone-sulbactum and the implication on empirical therapy in patients with cancer. 11th International Symposium on Febrile Neutropenia, Spain 2009.
  • Ghadyalpatil N., Banavali S., Kurkure P.,Arora B.,Bansal S.,Amare P., Gujral S., Choughule A., Soy L., Singh R. Excellent efficacy and tolerability of imatinib mesylate in pediatric chronic myeloid leukemia in a large cohort: Results from a tertiary care referral center in India. J Clin Oncol 27:15s, 2009 (suppl; abstr 10047).
  • Bajpai, K. Prabhash, A. Medhekar, R. Nair, P. Kurkure, N. Ghadyalpatil, S. Gupta, V. Noronha, P. D. Kudale, S. Banavali. Performance of MASCC score and other factors for identifying low-risk febrileneutropenic cancer patients. J. Clin Oncol 28, 2010 (suppl; abstr e19533).
  • V. Ostwal, N. Ghadyalpatil, K. Prabhash, H. Menon, R. Nair, M. Sengar, V. Noronha, S. Biswas, B. Bhosale, S. Banavali. Reactivation of latent viral hepatitis infection in patients of chronic myeloid leukemia treated with imatinib mesylate: Experience from a tertiary cancer center in India. J Clin Oncol 28:15s, 2010 (suppl; abstr 6593).
  • N. Ghadyalpatil, K. Prabhash, H. Menon, R. Nair, S. Banavali, V. Noronha, V. Wabale, R. Singh, G. Goyal, V. Ostwal; Tuberculosis infection in chronic myeloid leukemia (CML) patients treated with imatinib. J Clin Oncol 28:15s, 2010 (suppl; abstr 6594).
• Oral Presentations
  • Ghadyalpatil N, Menon H, Bharath R, Prabhash K, Vora T, Parikh PM. Impact of Maintenance Chemotherapy with Weekly Paclitaxel in Advanced Non Small Cell Lung Cancer (NSCLC) patients treated with Gemcitabine and Carboplatin – Prospective Single Arm Study. Asia Pacific Lung Cancer Conference (APLCC), Hyderabad 2008.
• Books Authored
  • Chapter on Neoadjuvant Systemic Therapy in Breast Cancer: Current Perspectives in Strategies for Breast Cancer Management: Expert Reviews, an educational handbook 2019.
  • Thrombosis and Cancer. Sudeep Gupta, Nikhil Ghadyalpatil, Gautam Goyal. Evidence Based Management of Cancers in India. (Co-author)
  • All about Stents and PORTs. Navin Khattry, Nikhil Ghadyalpatil. Hematology 2008 (Book By Dr. M.B Agrawal)
• Reviewer and Editor
  • Executive Editor, South Asian Journal of Cancer
  • International Journal of Cancer (IJC)
  • Indian Journal of Medical and Paediatric Oncology (IJMPO)
  • South Asian Journal of Cancer (SAJC)

Awards and Achievements

• MRCP SCE 2020 UK
• ASCO-International Development and Education Award (IDEA), Karmanos Cancer Center, Wayne State University, Detroit, 2010
• DM Medical Oncology (1st Rank, Tata Memorial, Mumbai) 2009
• European Certification in Medical Oncology (ECMO), Barcelona, Spain, 2007
• Gold Medal for Securing First Position in PG Examination from KEMH, Mumbai, India, 2006
• B Braun Foundation Scholarship (National Scholarship) for Outstanding Performance during PG, 2003
• Nagpur University Medal and Prize-Topper in Physiology, 1997

FAQ'S

1. 1. Why do patients frequently visit Dr. Nikhil S Ghadyalpatil?
   

   Patients frequently visit Dr. Nikhil S Ghadyalpatil to receive chemotherapy for solid and hematolymphoid malignancies, targeted therapy, immunotherapy, head and neck cancer, breast cancer.

2. 2. What is Dr. Nikhil S Ghadyalpatil's education qualification?
   

   Dr. Nikhil S Ghadyalpatil has the following qualifications-MD, DNB, MNAMS, PDCR, DM (Medical Oncology).

3. 3. What does Dr. Nikhil S Ghadyalpatil specializes in?
   

   Dr. Nikhil S Ghadyalpatil is specialized in immunotherapy, hematological malignancies, solid tumors, pediatric oncology, precision oncology, breast cancer, lung cancer & colon cancer.

4. 4. Where does Dr. Nikhil S Ghadyalpatil practice?
   

   Dr. Nikhil S Ghadyalpatil practices at Yashoda Hospitals – Somajiguda.

5. 5. How can I book Dr. Nikhil S Ghadyalpatil appointment?
   

   You can book Dr. Nikhil S Ghadyalpatil’s appointment online for Online video consultation and Opd consultation.

6. 6. How many years of experience does Dr. Nikhil S Ghadyalpatil have?
   

   Dr. Nikhil S Ghadyalpatil has 17 years of experience as a Medical Oncologist & Hemato-Oncologist.